top | item 31619201

(no title)

monus | 3 years ago

They're conducting a Phase II trial now with 85 participants, the completion date is set to November 2022.

https://clinicaltrials.gov/ct2/show/NCT04375657

discuss

order

losvedir|3 years ago

I'm getting somewhat interested in this topic. How did you know about this trial? I'm curious what good news sources are to follow so I can see when the results are out.